Michael Petusky Analyst Performance

Research Analyst at Barrington Research

Michael Petusky is a stock analyst at Barrington Research focused in the medical sector, covering 16 publicly traded companies. Over the past year, Michael Petusky has issued 72 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Michael Petusky's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Petusky's coverage history, rating activity, and performance tendencies â€” helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 124 Last 11 Years
Buy Recommendations: 90.83% 109 Buy Ratings
Companies Covered: 16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.8%	1 ratings
Buy	90.0%	108 ratings
Hold	8.3%	10 ratings
Sell	0.8%	1 ratings

Out of 120 total stock ratings issued by Michael Petusky at Barrington Research, the majority (90.0%) have been Buy recommendations, followed by 8.3% Hold, 0.8% Strong Buy, and 0.8% Sell.

Best & Worst Calls

Best Call
0000.0%
LMAT
Jul 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
OPK
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	87.5% of companies on NASDAQ	14 companies
NYSE	12.5% of companies on NYSE	2 companies

Michael Petusky, an analyst at Barrington Research, currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	81.3%
	Manufacturing 1 company	6.3%
	Business Services 1 company	6.3%
	Consumer Discretionary 1 company	6.3%

Michael Petusky of Barrington Research specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Business Services companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 3 companies	18.8%
MED/DENTAL - SUPP 3 companies	18.8%
MED - OUTP/HM CRE 2 companies	12.5%
MED INSTRUMENTS 2 companies	12.5%
MED - BIOMED/GENE 2 companies	12.5%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES 1 company	6.3%
TECHNOLOGY SERVICES 1 company	6.3%
MEDICAL SERVICES 1 company	6.3%
TRANSPORTATION SERVICES 1 company	6.3%

About Michael Petusky

Michael Petusky joined Barrington Research in 2014 as Managing Director & Senior Investment Analyst covering Healthcare Services and focusing currently on the pharmacy, home infusion, rehabilitation, chronic care management and wellness, and senior housing, as well as Dental Services and select Medical Device companies. Prior to joining Barrington Research, Mr. Petusky covered healthcare services stocks and select medical device ideas for Noble Financial Group (2007-2014), Thompson Davis & Co. (2002-2007), and Branch Cabell, and its successor firms (1995-2002). Mr. Petusky has been quoted in national publications such as Business Week, Investor’s Business Daily, Smart Money Magazine, and The Washington Post. In 2010, he received a StarMine analyst award for his stock-picking ability among analysts covering Healthcare Services. Mr. Petusky has a B.B.A. (Finance-concentration) from the University of Richmond (1991) and also holds the Chartered Financial Analyst designation.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
USPH U.S. Physical Therapy	5/13/2026	Lower Price Target	$61.05	$90.00	Outperform
HAE Haemonetics	5/12/2026	Lower Price Target	$52.32	$89.00	Outperform
LMAT LeMaitre Vascular	5/6/2026	Boost Price Target	$110.22	$120.00	Outperform
OPCH Option Care Health	5/1/2026	Lower Price Target	$20.02	$32.00	Outperform
OPK OPKO Health	4/29/2026	Downgrade	$1.21		Market Perform
LFCR Lifecore Biomedical	4/29/2026	Boost Price Target	$4.94	$6.00	Outperform
MMSI Merit Medical Systems	4/20/2026	Set Price Target	$71.23	$107.00
MMSI Merit Medical Systems	4/20/2026	Lower Price Target	$70.93	$107.00	Outperform
OFIX Orthofix Medical	4/10/2026	Reiterated Rating	$12.42	$17.00	Outperform
LFCR Lifecore Biomedical	3/24/2026	Reiterated Rating	$4.03	$5.50	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
LFCR Lifecore Biomedical	3/17/2026	Upgrade	$4.36	$5.50	Outperform
BVS Bioventus	3/6/2026	Boost Price Target	$8.37	$14.00	Outperform
XRAY DENTSPLY SIRONA	3/2/2026	Boost Price Target	$14.68	$17.00	Outperform
OPK OPKO Health	3/2/2026	Lower Price Target	$1.19	$1.50	Outperform
ANIK Anika Therapeutics	2/27/2026	Boost Price Target	$14.36	$17.00	Outperform
LMAT LeMaitre Vascular	2/26/2026	Boost Price Target	$113.69	$105.00	Outperform
HSIC Henry Schein	2/25/2026	Set Price Target	$81.87	$97.00	Outperform
OFIX Orthofix Medical	2/25/2026	Lower Price Target	$13.04	$17.00	Outperform
MMSI Merit Medical Systems	2/25/2026	Boost Price Target	$79.23	$109.00	Outperform
USPH U.S. Physical Therapy	2/20/2026	Reiterated Rating	$86.26	$103.00	Outperform
LMAT LeMaitre Vascular	2/20/2026	Reiterated Rating	$91.86	$95.00	Outperform
OFIX Orthofix Medical	2/17/2026	Reiterated Rating	$13.38	$18.00	Outperform
BVS Bioventus	2/9/2026	Initiated Coverage	$8.51	$13.00	Outperform
HAE Haemonetics	2/6/2026	Set Price Target	$65.00	$94.00
HAE Haemonetics	2/2/2026	Reiterated Rating	$66.54	$93.00	Outperform
OPCH Option Care Health	1/16/2026	Boost Price Target	$36.11	$42.00	Outperform
HAE Haemonetics	1/12/2026	Boost Price Target	$82.01	$93.00	Outperform
ANIK Anika Therapeutics	1/9/2026	Reiterated Rating	$9.55	$16.00	Outperform
VRME VerifyMe	1/6/2026	Boost Price Target	$1.07	$1.50	Outperform
USPH U.S. Physical Therapy	1/5/2026	Reiterated Rating	$81.91	$103.00	Outperform
XRAY DENTSPLY SIRONA	1/5/2026	Reiterated Rating	$11.51	$14.00	Outperform
XRAY DENTSPLY SIRONA	12/16/2025	Reiterated Rating	$11.20	$14.00	Outperform
VRME VerifyMe	11/18/2025	Set Price Target	$0.76	$1.00
SRDX Surmodics	11/14/2025	Reiterated Rating	$41.49		Underperform
MMSI Merit Medical Systems	11/14/2025	Reiterated Rating	$85.39	$106.00	Outperform
XRAY DENTSPLY SIRONA	11/10/2025	Lower Price Target	$11.18	$14.00	Outperform
HAE Haemonetics	11/7/2025	Boost Price Target	$67.66	$90.00	Outperform
ANIK Anika Therapeutics	11/6/2025	Boost Price Target	$9.73	$16.00	Outperform
HSIC Henry Schein	11/5/2025	Set Price Target	$71.58	$79.00	Outperform
OFIX Orthofix Medical	11/5/2025	Boost Price Target	$14.96	$18.00	Outperform
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
MMSI Merit Medical Systems	10/31/2025	Boost Price Target	$89.09	$106.00	Outperform
OPCH Option Care Health	10/31/2025	Reiterated Rating	$26.20	$38.00	Outperform
OPK OPKO Health	10/30/2025	Reiterated Rating	$1.43	$2.25	Outperform
XRAY DENTSPLY SIRONA	10/29/2025	Reiterated Rating	$13.07	$18.00	Outperform
USPH U.S. Physical Therapy	10/24/2025	Reiterated Rating	$91.14	$103.00	Outperform
OFIX Orthofix Medical	10/23/2025	Reiterated Rating	$16.23	$17.00	Outperform
HSIC Henry Schein	10/22/2025	Reiterated Rating	$64.23	$78.00	Outperform
HAE Haemonetics	10/21/2025	Reiterated Rating	$50.76	$86.00	Outperform
LMAT LeMaitre Vascular	10/15/2025	Reiterated Rating	$87.38	$95.00	Outperform
MMSI Merit Medical Systems	10/7/2025	Reiterated Rating	$83.31	$103.00	Outperform
OFIX Orthofix Medical	9/23/2025	Reiterated Rating	$14.98	$17.00	Outperform
OPCH Option Care Health	9/23/2025	Reiterated Rating	$27.67	$38.00	Outperform
MMSI Merit Medical Systems	9/23/2025	Reiterated Rating	$83.46	$103.00	Outperform
LMAT LeMaitre Vascular	9/23/2025	Reiterated Rating	$91.55	$95.00	Outperform
HSIC Henry Schein	9/23/2025	Reiterated Rating	$69.24	$78.00	Outperform
HAE Haemonetics	9/23/2025	Reiterated Rating	$51.44	$86.00	Outperform
ANIK Anika Therapeutics	9/23/2025	Reiterated Rating	$9.27	$15.00	Outperform
VRME VerifyMe	8/14/2025	Boost Price Target	$0.93	$1.50	Outperform
SRDX Surmodics	8/11/2025	Reiterated Rating	$35.41		Market Perform
XRAY DENTSPLY SIRONA	8/8/2025	Lower Price Target	$12.88	$18.00	Outperform
HAE Haemonetics	8/8/2025	Lower Price Target	$55.49	$86.00	Outperform
USPH U.S. Physical Therapy	8/8/2025	Boost Price Target	$83.47	$103.00	Outperform
LMAT LeMaitre Vascular	8/6/2025	Upgrade	$85.60	$95.00	Outperform
HSIC Henry Schein	8/6/2025	Lower Price Target	$64.83	$78.00	Outperform
MMSI Merit Medical Systems	7/31/2025	Reiterated Rating	$82.96	$103.00	Outperform
ANIK Anika Therapeutics	7/31/2025	Lower Price Target	$8.10	$15.00	Outperform
XRAY DENTSPLY SIRONA	7/22/2025	Reiterated Rating	$15.84	$21.00	Outperform
LMAT LeMaitre Vascular	7/22/2025	Reiterated Rating	$80.92		Market Perform
HAE Haemonetics	7/11/2025	Reiterated Rating	$78.35	$95.00	Outperform
OPCH Option Care Health	7/10/2025	Reiterated Rating	$30.59	$38.00	Outperform
USPH U.S. Physical Therapy	7/1/2025	Reiterated Rating	$78.31	$98.00	Outperform
OFIX Orthofix Medical	6/23/2025	Upgrade	$10.34	$16.00	Strong-Buy
MODV ModivCare	5/12/2025	Reiterated Rating	$1.18		Market Perform
XRAY DENTSPLY SIRONA	5/12/2025	Boost Price Target	$15.81	$21.00	Outperform
ANIK Anika Therapeutics	5/12/2025	Lower Price Target	$11.64	$19.00	Outperform
HSIC Henry Schein	5/6/2025	Lower Price Target	$66.58	$86.00	Outperform
OPK OPKO Health	5/1/2025	Reiterated Rating	$1.34	$2.25	Outperform
OPCH Option Care Health	4/30/2025	Reiterated Rating	$30.69	$38.00	Outperform
MMSI Merit Medical Systems	4/25/2025	Lower Price Target	$94.67	$103.00	Outperform
OPCH Option Care Health	4/21/2025	Reiterated Rating	$32.09	$38.00	Outperform
MMSI Merit Medical Systems	4/11/2025	Reiterated Rating	$91.54	$111.00	Outperform
ANIK Anika Therapeutics	3/13/2025	Lower Price Target	$17.11	$20.00	Outperform
OPK OPKO Health	3/12/2025	Reiterated Rating	$1.80	$2.25	Outperform
VRME VerifyMe	3/7/2025	Lower Price Target	$0.72	$1.25	Outperform
MODV ModivCare	3/7/2025	Lower Price Target	$2.96	$6.00	Outperform
LMAT LeMaitre Vascular	2/28/2025	Downgrade	$99.91		Market Perform
USPH U.S. Physical Therapy	2/28/2025	Lower Price Target	$82.25	$98.00	Outperform
XRAY DENTSPLY SIRONA	2/28/2025	Lower Price Target	$16.61	$20.00	Outperform
OPK OPKO Health	2/28/2025	Reiterated Rating	$1.73	$2.25	Outperform
OPCH Option Care Health	2/27/2025	Boost Price Target	$33.15	$38.00	Outperform
I was right about SpaceX (Ad) Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day. See how to claim your stake in SpaceX before the public can
HSIC Henry Schein	2/26/2025	Reiterated Rating	$75.82	$90.00	Outperform
MMSI Merit Medical Systems	2/26/2025	Lower Price Target	$100.45	$111.00	Outperform
HAE Haemonetics	2/7/2025	Lower Price Target	$62.95	$95.00	Outperform
HSIC Henry Schein	1/30/2025	Boost Price Target	$79.87	$90.00	Outperform
MMSI Merit Medical Systems	1/29/2025	Boost Price Target	$109.03	$115.00	Outperform
OPCH Option Care Health	1/14/2025	Boost Price Target	$28.26	$33.00	Outperform

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.